-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
DTRT Health Acquisition Corp. (NASDAQ:DTRT) Sees Large Drop in Short Interest
DTRT Health Acquisition Corp. (NASDAQ:DTRT) Sees Large Drop in Short Interest
DTRT Health Acquisition Corp. (NASDAQ:DTRT – Get Rating) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 10,400 shares, a decline of 31.6% from the November 15th total of 15,200 shares. Based on an average daily volume of 82,400 shares, the short-interest ratio is presently 0.1 days.
Hedge Funds Weigh In On DTRT Health Acquisition
Hedge funds have recently made changes to their positions in the business. Captrust Financial Advisors acquired a new position in shares of DTRT Health Acquisition in the 1st quarter worth approximately $48,000. UBS Group AG increased its position in shares of DTRT Health Acquisition by 1,627.2% in the second quarter. UBS Group AG now owns 8,688 shares of the company's stock worth $87,000 after acquiring an additional 8,185 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new position in shares of DTRT Health Acquisition in the third quarter worth approximately $106,000. Goldman Sachs Group Inc. purchased a new position in shares of DTRT Health Acquisition in the first quarter worth approximately $140,000. Finally, Royal Bank of Canada increased its position in shares of DTRT Health Acquisition by 215.0% in the first quarter. Royal Bank of Canada now owns 16,190 shares of the company's stock worth $162,000 after acquiring an additional 11,050 shares in the last quarter. Institutional investors and hedge funds own 64.50% of the company's stock.
Get DTRT Health Acquisition alerts:DTRT Health Acquisition Stock Performance
Shares of DTRT traded up $0.08 during mid-day trading on Wednesday, hitting $10.28. The company's stock had a trading volume of 443,585 shares, compared to its average volume of 79,807. The firm has a 50-day moving average price of $10.23 and a 200 day moving average price of $10.14. DTRT Health Acquisition has a fifty-two week low of $9.90 and a fifty-two week high of $11.34.
About DTRT Health Acquisition
(Get Rating)DTRT Health Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was incorporated in 2021 and is based in Oak Brook, Illinois.
Featured Stories
- Get a free copy of the StockNews.com research report on DTRT Health Acquisition (DTRT)
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- Harpoon Therapeutics Remains Volatile After Promising News
- Will Nordstrom Stock be the Grinch This Year?
Receive News & Ratings for DTRT Health Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DTRT Health Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
DTRT Health Acquisition Corp. (NASDAQ:DTRT – Get Rating) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 10,400 shares, a decline of 31.6% from the November 15th total of 15,200 shares. Based on an average daily volume of 82,400 shares, the short-interest ratio is presently 0.1 days.
納斯達克健康收購公司(DTRT-GET Rating)看到空頭股數在11月份出現了大幅下滑。截至11月30日,空頭股數共有10,400股,較11月15日的15,200股下降了31.6%。以日均成交量82,400股計算,目前短息比率為0.1天。
Hedge Funds Weigh In On DTRT Health Acquisition
對沖基金參與DTRT Health收購
Hedge funds have recently made changes to their positions in the business. Captrust Financial Advisors acquired a new position in shares of DTRT Health Acquisition in the 1st quarter worth approximately $48,000. UBS Group AG increased its position in shares of DTRT Health Acquisition by 1,627.2% in the second quarter. UBS Group AG now owns 8,688 shares of the company's stock worth $87,000 after acquiring an additional 8,185 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new position in shares of DTRT Health Acquisition in the third quarter worth approximately $106,000. Goldman Sachs Group Inc. purchased a new position in shares of DTRT Health Acquisition in the first quarter worth approximately $140,000. Finally, Royal Bank of Canada increased its position in shares of DTRT Health Acquisition by 215.0% in the first quarter. Royal Bank of Canada now owns 16,190 shares of the company's stock worth $162,000 after acquiring an additional 11,050 shares in the last quarter. Institutional investors and hedge funds own 64.50% of the company's stock.
對沖基金最近對其在該業務中的頭寸進行了調整。CapTrust Financial Advisors在第一季度收購了DTRT Health收購公司的新股票,價值約4.8萬美元。瑞銀集團第二季度增持DTRT Health收購股份1,627.2%。瑞銀集團(UBS Group AG)在上個季度增持了8,185股瑞銀股票後,目前持有8,688股該公司股票,價值87,000美元。景觀資本管理公司在第三季度購買了DTRT Health收購的新頭寸,價值約10.6萬美元。高盛股份有限公司在第一季度購買了DTRT Health收購的新頭寸,價值約140,000美元。最後,加拿大皇家銀行在第一季度增持了DTRT Health收購的股份215.0。加拿大皇家銀行在上個季度增持了11,050股後,現在持有該公司16,190股股票,價值162,000美元。機構投資者和對沖基金持有該公司64.50%的股票。
DTRT Health Acquisition Stock Performance
DTRT Health Acquisition股票表現
Shares of DTRT traded up $0.08 during mid-day trading on Wednesday, hitting $10.28. The company's stock had a trading volume of 443,585 shares, compared to its average volume of 79,807. The firm has a 50-day moving average price of $10.23 and a 200 day moving average price of $10.14. DTRT Health Acquisition has a fifty-two week low of $9.90 and a fifty-two week high of $11.34.
在週三午盤交易中,DTRT的股價上漲0.08美元,達到10.28美元。該公司股票的成交量為445,585股,而其平均成交量為79,807股。該公司的50日移動均線價格為10.23美元,200日移動均線價格為10.14美元。DTRT Health Acquisition的收購價為9.90美元,為52周低點,52周高點為11.34美元。
About DTRT Health Acquisition
關於DTRT Health Acquisition
DTRT Health Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was incorporated in 2021 and is based in Oak Brook, Illinois.
DTRT Health Acquisition Corp.沒有重大業務。擬與一家或多家經營性企業或資產進行合併、資本換股、資產收購、股票購買、重組或其他類似的業務合併。該公司成立於2021年,總部設在伊利諾伊州的奧克布魯克。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on DTRT Health Acquisition (DTRT)
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- Harpoon Therapeutics Remains Volatile After Promising News
- Will Nordstrom Stock be the Grinch This Year?
- 免費獲取StockNews.com關於DTRT健康獲取(DTRT)的研究報告
- REV集團引領專用車製造商走高
- NVIDIA VS AMD:2023年哪一種更好?
- FDA的批准能支持DexCom,Inc.嗎?
- 魚叉治療公司在有希望的消息傳出後仍不穩定
- 諾德斯特龍股票公司會成為今年的格林奇嗎?
Receive News & Ratings for DTRT Health Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DTRT Health Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受每日DTRT健康獲取的新聞和評級-在下面輸入您的電子郵件地址,以通過MarketBeat.com的免費每日電子郵件時事通訊接收對DTRT Health Acquisition和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧